申请人:Bayer Aktiengesellschaft
公开号:US20200369633A1
公开(公告)日:2020-11-26
The present invention provides dihydrooxydiazinone compounds of general formula (I): in which R
1
, R
2
, R
3
, and R
4
, are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative diseases, as a sole agent or in combination with other active ingredients.